A randomized study comparing interferon (IFNα) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML) by Kühr, T., Burgstaller, S., Apfelbeck, U., Linkesch, W., Seewann, H., Fridrik, M., Michlmayr, G., Krieger, O., Lutz, D., Lin, W., Pont, J., Köck, L., Abbrederis, K., Baldinger, C., Buder, R., Geissler, D., Hausmaninger, H., Lang, A., Zabernigg, A., Duba, C., Hilbe, W., Eisterer, W., Fiegl, M., Greil, R., Gastl, G., Thaler, J.

Get full text

Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis by Beham-Schmid, Christine, Apfelbeck, Ute, Sill, Heinz, Tsybrovsky, Oleksiy, Höfler, Gerald, Haas, Oskar A., Linkesch, Werner

Get full text

Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01):: a pilot study by Kühr, T, Eisterer, W, Apfelbeck, U, Linkesch, W, Bechter, O, Zabernigg, A, Geissler, K, Barbieri, G, Duba, C, Gastl, G, Thaler, J

Get full text

Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma by Neumeister, Peter, Strunk, Dirk, Apfelbeck, Ute, Sill, Heinz, Linkesch, Werner

Get full text

Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C by Hilbe, W, Kühr, T, Apfelbeck, U, Fridrik, M, Seewann, H, Stöger, M, Linkesch, W, Pont, J, Baldinger, C, Hartner, E, Bernhart, M, Geissler, D, Krieger, O, Lang, A, Lin, W, Ludwig, H, Duba, C, Greil, R, Gast, G, Thaler, J

Get full text

Interferon- α for the treatment of elderly patients with chronic myeloid leukaemia by Hilbe, Wolfgang, Apfelbeck, Ute, Fridrik, Michael, Bernhart, Marianne, Niessner, Herwig, Abbrederis, Klaus, Michlmayr, Gerhard, Pont, Jörg, Linkesch, Werner, Hausmaninger, Hubert, Arneitz, Klaus, Baldinger, Christian, Duba, Christoph, Eisterer, Wolfgang, Greil, Richard, Konwalinka, Günther, Niederwieser, Dietger, Gastl, Günther, Thaler, Josef

Get full text

Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01) by Kühr, T, Eisterer, W, Apfelbeck, U, Linkesch, W, Bechter, O, Zabernigg, A, Geissler, K, Barbieri, G, Duba, C, Gastl, G, Thaler, J

Get full text

Dose Escalation of Ara-C May Improve Response Rates in a Subgroup of Chronic Myeloid Leukemia Patients with Poor Response to Interferon-α and Low-dose Ara-C by Hilbe, W., Kühr, T., Apfelbeck, U., Fridrik, M., Seewann, H., Stöger, M., Linkesch, W., Pont, J., Baldinger, C., Hartner, E., Bernhart, M., Geissler, D., Krieger, O., Lang, A., Lin, W., Ludwig, H., Duba, C., Greil, R., Gastl, G., Thaler, Josef

Get full text

Interferon-alpha-2c and LD ara-C for the treatment of patients with CML : Results of the Austrian multi-center phase II study by THALER, J, HILBE, W, ABBREDERIS, K, GEISSLER, D, HAUSMANINGER, H, LIN, W, LUDWIG, H, LANG, A, DUBA, C, FLUCKINGER, T, GREIL, R, GRÜNEWALD, K, APFELBECK, U, KONWALINKA, G, NIEDERWIESER, D, FRIDRIK, M, LINKESCH, W, SILL, H, SEEWANN, H, PONT, J, BERNHART, M, STÖGER, M, NIESSNER, H

Get full text

Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma by Neumeister, P, Strunk, D, Apfelbeck, U, Sill, H, Linkesch, W

Get full text